Dr Sven Bostyn Lic.Jur., LLM, PhD
Associate Professor of Biomedical Innovation Law
Law Center for Advanced studies in Biomedical Innovation Law
Regulatory Challenges to Life Science IP's
Tuesday, November 27th, 2018
This session will cover the following topics:
Sufficiency vs. Inventive Step
European Case Law examples
UK Supreme Court battles (Warner-Lambert vs. Actavis/Pregabalin)
Fairness and Practicality
Effective IP Management and Monetisation Strategies
Monday, November 28th, 2078
Is there anything special about patenting antibodies?
Contested area of law – Pharmaceuticals moving away from chemical products and more towards biotech products
Previously, patents were granted generously, with broad scope – Since screening has improved, requirement to prove more defined antibodies to secure protection
How to overcome the issue of inventiveness?